Multivariable regression analysis of perioperative parameters for a novel pulsed solid-state Thulium: YAG laser with high peak power versus Holmium: YAG laser in prostate enucleation - Scorecard - MDSpire
Advertisement
Multivariable regression analysis of perioperative parameters for a novel pulsed solid-state Thulium: YAG laser with high peak power versus Holmium: YAG laser in prostate enucleation
Clinical Scorecard: Analysis of Perioperative Factors Using Multivariable Regression for a New High-Peak Power Pulsed Solid-State Thulium: YAG Laser Compared to Holmium: YAG Laser in Prostate Enucleation
Laser enucleation of the prostate using pulsed solid-state Thulium: YAG laser versus Holmium: YAG laser
Target Population
Men with BPH refractory to medical treatment, including those with refractory urinary retention or hematuria
Care Setting
Surgical urology setting performing endoscopic enucleation of the prostate
Key Highlights
Pulsed solid-state Thulium: YAG laser has higher peak power (3,700 W) and wavelength (2013 nm) close to water absorption peak, enabling efficient tissue ablation with less penetration and damage than Holmium: YAG laser.
Laser enucleation of the prostate (LEP) is recommended over TURP due to lower bleeding risk and shorter hospitalization.
Both HoLEP and pulsed ThuLEP performed with en-bloc technique by experienced surgeons using standardized protocols including monopolar electrocautery for hemostasis.
Guideline-Based Recommendations
Diagnosis
Diagnosis of BPH causing bladder outlet obstruction confirmed by clinical symptoms, prostate volume measurement, PSA levels, and uroflowmetry.
Management
Endoscopic enucleation of the prostate (EEP) is standard surgical treatment regardless of prostate size.
Laser enucleation (HoLEP or pulsed ThuLEP) preferred due to lower bleeding risk and shorter hospital stay compared to TURP.
Antiplatelet therapy with aspirin may be continued; clopidogrel paused 7 days preoperatively; anticoagulants paused or bridged as per protocol.
Monitoring & Follow-up
Perioperative monitoring includes duration of surgery, enucleation time, laser energy used, enucleated tissue weight, catheterization duration, hospitalization length, and postoperative pain scores.
Postoperative follow-up up to 30 days to assess complications and recovery.
Risks
Potential bleeding controlled by monopolar electrocautery post-enucleation.
Management of anticoagulants and antiplatelet agents to minimize bleeding risk.
Patient & Prescribing Data
Men with symptomatic BPH refractory to medical therapy undergoing surgical enucleation.
Pulsed solid-state Thulium: YAG laser offers efficient ablation with less tissue damage and charring compared to Holmium: YAG laser, potentially improving perioperative outcomes.
Clinical Best Practices
Use of standardized en-bloc enucleation technique by experienced surgeons.
Preoperative management of antiplatelet and anticoagulant therapies according to institutional protocols.
Application of monopolar electrocautery for hemostasis after laser enucleation.
Use of continuous bladder irrigation postoperatively with three-way urinary catheter.